Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study

Korea |  News | 0 Comment | 22 Feb, 2019

Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing new drugs and APIs (Active Pharmaceutical Ingredients) has announced...Read more

Korean govt to inject $2.6B to develop biotech in 2019

Korea |  News | 0 Comment | 20 Feb, 2019

According to reports from the Korean Herald,  the government of Korea will spend 2.93 trillion won (US$2.61 billion) this year to develop new biotechnology, as part of efforts to becom...Read more

ROKIT brings innovative 3D bioprinting strategy for skin regeneration

Korea |  News | 0 Comment | 20 Feb, 2019

ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic strategies using three-dimensional (3D) biofabrication technologies for ...Read more

SK Biopharma to take antiepileptic drug to Europe

Korea |  News | 0 Comment | 18 Feb, 2019

SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe...Read more

Bridge Bio presents Preclinical, Ph I study results for BBT-401

Korea |  News | 0 Comment | 12 Feb, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company presented the preclinical and the Phase I study results for ...Read more

OliX announces clinical candidate for Geographic Atrophy treatment

Korea |  News | 0 Comment | 29 Jan, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clinical candidate for the treatment of Geographic Atrophy (GA), which is...Read more

US FDA approves Samsung Bioepis' first oncology drug

Korea |  News | 0 Comment | 21 Jan, 2019

Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencing HERCEPTIN (trastuzumab), across all eligible indications, name...Read more

Bridge Bio receives FDA ODD for IPF drug

Korea |  News | 0 Comment | 17 Jan, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the U.S. Food and Dr...Read more

Glenmark enters commercialization agreement with Yuhan Corp

Korea |  News | 0 Comment | 10 Jan, 2019

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has announced that its Suisse subsidiary, Glenmark Specialty S.A., has entered into an exclusive lice...Read more

Norgine, Korea Pharma ink deal to commercialise PLENVU in Korea

Korea |  News | 0 Comment | 08 Jan, 2019

NORGINE B.V. (Norgine), a leading European specialty pharmaceutical company and KOREA PHARMA CO., LTD. (Korea Pharma), a premier pharmaceutical manufacturer in Korea, today announced an exc...Read more

Gilead Sciences, Yuhan to treat advanced fibrosis due to NASH

Korea |  News | 0 Comment | 07 Jan, 2019

Gilead Sciences, Inc. and Yuhan Corporation has announced that the companies have entered into a licensing and collaboration agreement to co-develop novel therapeutic candidates for the tre...Read more

South Korea IVD Market 2017-2022; overview by ResearchAndMarkets

Korea |  News | 0 Comment | 02 Jan, 2019

South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, there is a growing demand for new technologies in the laboratory sect...Read more

Bridge Bio announces activation of clinical trial sites for Phase 2 study of UC drug candidate

Korea |  News | 0 Comment | 28 Dec, 2018

Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that the company has successfully activated clinical study sites for the Ph...Read more

Eventi Telematici, Penta Security strengthens partnership for DataBreast

Korea |  News | 0 Comment | 20 Dec, 2018

In recent years, several regulatory laws enforcing data privacy – that requires organizations to strengthen data protection -- have come into effect worldwide, including the EU's...Read more

Bridge Bio signs $40M license agreement with Daewoong Pharma

Korea |  News | 0 Comment | 19 Dec, 2018

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a license agreement with Daewoong Pharmaceutical Co., Ltd. for development o...Read more

Celltrion, Teva announce FDA approval of HERZUMA

Korea |  News | 0 Comment | 18 Dec, 2018

Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. have announced that the U.S. Food and Drug Administration (FDA) has approved HERZUMA [®] (trastuzumab-pkrb), a HER2/neu receptor ...Read more

Prestige, Cipla unite to sell cancer biosimilar HD201

Korea |  News | 0 Comment | 14 Dec, 2018

Prestige BioPharma (“Prestige”) has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which Cipla will hav...Read more

Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation

Korea |  News | 0 Comment | 13 Dec, 2018

UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Sciences, the life sciences division of the South Korean LG Group, recently ...Read more